The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Abstract
Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease of unknown etiology. It is characterized by alterations of the alveolar epithelium, myofibroblast activation, and increased extracellular matrix deposition. Recently, reactivation of the developmental WNT/β-catenin pathway has been linked with pulmonary fibrosis. The cell-specific mechanisms and mediators of WNT/β-catenin signaling in the lung, however, remain elusive. Here, we applied an unbiased gene expression screen to identify epithelial cell–specific mediators of WNT/β-catenin signaling. We found the proinflammatory cytokine IL-1β to be one of the most up-regulated genes in primary murine alveolar epithelial Type II (ATII) cells after WNT3a treatment. Increased transcript and protein expression of IL-1β upon WNT3a treatment was further detected in primary ATII cells by quantitative RT-PCR (log fold change, 2.0 ± 0.5) and ELISA (1.8-fold increase). We observed significant up-regulation of IL-1β and IL-6 in bronchoalveolar lavage fluid (BALF) in bleomycin-induced lung fibrosis in vivo. Importantly, primary fibrotic ATII cells isolated from lungs subjected to bleomycin secreted enhanced IL-1β and IL-6 in vitro. Furthermore, the orotracheal application of recombinant WNT protein in the Tcf optimal promoter (TOP)-β-galactosidase reporter animals led to WNT/β-catenin activation in epithelial cells, along with significant increases in IL-1β and IL-6 in vivo (2.7-fold and 6.0-fold increases, respectively). Finally, we found increased WNT3a protein in fibrotic alveolar epithelia, accompanied by enhanced IL-1β and IL-6 concentrations in BALF from patients with IPF. Taken together, our findings reveal that the alveolar epithelium is a relevant source of proinflammatory cytokines induced by active WNT/β-catenin in pulmonary fibrosis. Thus, WNT/interleukin signaling represents a novel link between developmental pathway reactivation and inflammation in the development of pulmonary fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Bleomycin and IL-1β–mediated pulmonary fibrosis is IL-17A dependent
Wilson, M. S., Madala, S. K., Ramalingam, T. R., Gochuico, B. R., Rosas, I. O., Cheever, A. W., & Wynn, T. A. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092121 · Cited by 730
Aberrant Wnt/β-Catenin Pathway Activation in Idiopathic Pulmonary Fibrosis
Chilosi, M., Poletti, V., Zamò, A., Lestani, M., Montagna, L., Piccoli, P., Pedron, S., Bertaso, M., Scarpa, A., Murer, B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64282-4 · Cited by 708
Königshoff, M., Kramer, M., Balsara, N., Wilhelm, J., Amarie, O. V., Jahn, A., Rose, F., Fink, L., Seeger, W., Schaefer, L., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci33950 · Cited by 558
Self-citationUric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis
Gasse, P., Riteau, N., Charron, S., Girre, S., Fick, L., Pétrilli, V., Tschopp, J., Lagente, V., Quesniaux, V. F. J., Ryffel, B., et al. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200808-1274oc · Cited by 410
Piguet, P. F., Vesin, C., Grau, G. E., & Thompson, R. C. (1993) · Cytokine · doi:10.1016/1043-4666(93)90024-y · Cited by 215
β-catenin signaling: a novel mediator of fibrosis and potential therapeutic target
Lam, A. P., & Gottardi, C. J. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834b3309 · Cited by 191
Moodley, Y. P., Scaffidi, A. K., Misso, N. L., Keerthisingam, C., McAnulty, R. J., Laurent, G. J., Mutsaers, S. E., Thompson, P. J., & Knight, D. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63658-9 · Cited by 165
Research works printed but not linked: 47
- Raghu, 2011, An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management, Am J Respir Crit Care Med, 183, 788, 10.1164/rccm.2009-040GL · DOI · Paper page
- Mura, 2012, Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study, Eur Respir J, 40, 101, 10.1183/09031936.00106011 · DOI · Paper page
- Fernandez, 2012, New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis, Lancet, 380, 680, 10.1016/S0140-6736(12)61144-1 · DOI · Paper page
- Selman, 2001, Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy, Ann Intern Med, 134, 136, 10.7326/0003-4819-134-2-200101160-00015 · DOI · Paper page
- Selman, 2008, Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?, PLoS Med, 5, e62, 10.1371/journal.pmed.0050062 · DOI · Paper page
- Konigshoff, 2008, Functional WNT signaling is increased in idiopathic pulmonary fibrosis, PLoS ONE, 3, e2142, 10.1371/journal.pone.0002142 · DOI · Paper page
- Chapman, 2011, Epithelial–mesenchymal interactions in pulmonary fibrosis, Annu Rev Physiol, 73, 413, 10.1146/annurev-physiol-012110-142225 · DOI · Paper page
- Konigshoff, 2010, WNT signaling in lung disease: a failure or a regeneration signal?, Am J Respir Cell Mol Biol, 42, 21, 10.1165/rcmb.2008-0485TR · DOI · Paper page
- Zemans, 2011, Neutrophil transmigration triggers repair of the lung epithelium via beta-catenin signaling, Proc Natl Acad Sci USA, 108, 15990, 10.1073/pnas.1110144108 · DOI · Paper page
- Henderson, 2010, Inhibition of WNT/beta-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosis, Proc Natl Acad Sci USA, 107, 14309, 10.1073/pnas.1001520107 · DOI · Paper page
- Ulsamer, 2012, Axin pathway activity regulates in vivo PY654–beta-catenin accumulation and pulmonary fibrosis, J Biol Chem, 287, 5164, 10.1074/jbc.M111.322123 · DOI
- DasGupta, 1999, Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation, Development, 126, 4557, 10.1242/dev.126.20.4557 · DOI · Paper page
- Pfaff, 2011, Dickkopf proteins influence lung epithelial cell proliferation in idiopathic pulmonary fibrosis, Eur Respir J, 37, 79, 10.1183/09031936.00142409 · DOI
- Konigshoff, 2007, The angiotensin II receptor 2 is expressed and mediates angiotensin II signaling in lung fibrosis, Am J Respir Cell Mol Biol, 37, 640, 10.1165/rcmb.2006-0379TR · DOI
- Flozak, 2010, Beta-catenin/T-cell factor signaling is activated during lung injury and promotes the survival and migration of alveolar epithelial cells, J Biol Chem, 285, 3157, 10.1074/jbc.M109.070326 · DOI
- Corti, 1996, Isolation and primary culture of murine alveolar Type II cells, Am J Respir Cell Mol Biol, 14, 309, 10.1165/ajrcmb.14.4.8600933 · DOI · Paper page
- Kolb, 2001, Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis, J Clin Invest, 107, 1529, 10.1172/JCI12568 · DOI · Paper page
- Gasse, 2007, IL-1R1/MyD88 signaling and the inflammasome are essential in pulmonary inflammation and fibrosis in mice, J Clin Invest, 117, 3786
- Phan, 1992, Lung cytokine production in bleomycin-induced pulmonary fibrosis, Exp Lung Res, 18, 29, 10.3109/01902149209020649 · DOI · Paper page
- Tanjore, 2013, Beta-catenin in the alveolar epithelium protects from lung fibrosis following intratracheal bleomycin, Am J Respir Crit Care Med, 187, 630, 10.1164/rccm.201205-0972OC · DOI
- Kneidinger, 2011, Activation of the WNT/beta-catenin pathway attenuates experimental emphysema, Am J Respir Crit Care Med, 183, 723, 10.1164/rccm.200910-1560OC · DOI · Paper page
- Geiser, 2001, Pulmonary edema fluid from patients with acute lung injury augments in vitro alveolar epithelial repair by an IL-1beta–dependent mechanism, Am J Respir Crit Care Med, 163, 1384, 10.1164/ajrccm.163.6.2006131 · DOI · Paper page
- Geiser, 2000, Interleukin-1beta augments in vitro alveolar epithelial repair, Am J Physiol Lung Cell Mol Physiol, 279, L1184, 10.1152/ajplung.2000.279.6.L1184 · DOI
- Lam, 2011, Nuclear beta-catenin is increased in systemic sclerosis pulmonary fibrosis and promotes lung fibroblast migration and proliferation, Am J Respir Cell Mol Biol, 45, 915, 10.1165/rcmb.2010-0113OC · DOI
- Nunes, 2008, GSK-3/beta-catenin signaling axis in airway smooth muscle: role in mitogenic signaling, Am J Physiol Lung Cell Mol Physiol, 294, L1110, 10.1152/ajplung.00500.2007 · DOI
- Wei, 2012, WNT/beta-catenin signaling is hyperactivated in systemic sclerosis and induces Smad-dependent fibrotic responses in mesenchymal cells, Arthritis Rheum, 64, 2734, 10.1002/art.34424 · DOI · Paper page
- Douglas, 2000, Idiopathic pulmonary fibrosis: impact of oxygen and colchicine, prednisone, or no therapy on survival, Am J Respir Crit Care Med, 161, 1172, 10.1164/ajrccm.161.4.9907002 · DOI · Paper page
- Agostini, 2006, Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis, Proc Am Thorac Soc, 3, 357, 10.1513/pats.200601-010TK · DOI · Paper page
- Wynn, 2011, Integrating mechanisms of pulmonary fibrosis, J Exp Med, 208, 1339, 10.1084/jem.20110551 · DOI · Paper page
- Eda, 2011, Interleukin-1beta–induced interleukin-6 production in A549 cells is mediated by both phosphatidylinositol 3–kinase and interleukin-1 receptor–associated kinase–4, Cell Biol Int, 35, 355, 10.1042/CBI20100247 · DOI
- Yan, 2012, CCAAT/enhancer-binding protein gamma is a critical regulator of IL-1beta–induced IL-6 production in alveolar epithelial cells, PLoS ONE, 7, e35492, 10.1371/journal.pone.0035492 · DOI
- Ryu, 2006, Opposing roles of WNT-5a and WNT-11 in interleukin-1beta regulation of Type II collagen expression in articular chondrocytes, J Biol Chem, 281, 22039, 10.1074/jbc.M601804200 · DOI
- Ge, 2009, Role of WNT-5a in interleukin-1beta–induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes, Arthritis Rheum, 60, 2714, 10.1002/art.24779 · DOI
- Ma, 2012, A WNT/beta-catenin negative feedback loop inhibits interleukin-1–induced matrix metalloproteinase expression in human articular chondrocytes, Arthritis Rheum, 64, 2589, 10.1002/art.34425 · DOI
- Katoh, 2007, STAT3-induced WNT5a signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis and cancer, Int J Mol Med, 19, 273
- Pan, 1996, Co-expression of TNF alpha and IL-1 beta in human acute pulmonary fibrotic diseases: an immunohistochemical analysis, Pathol Int, 46, 91, 10.1111/j.1440-1827.1996.tb03584.x · DOI
- Fan, 2001, Interleukin-1 induces tubular epithelial–myofibroblast transdifferentiation through a transforming growth factor–beta1–dependent mechanism in vitro, Am J Kidney Dis, 37, 820, 10.1016/S0272-6386(01)80132-3 · DOI
- Doerner, 2009, TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids, Respir Res, 10, 100, 10.1186/1465-9921-10-100 · DOI · Paper page
- Zhou, 2012, Interactions between beta-catenin and transforming growth factor–beta signaling pathways mediate epithelial–mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element–binding protein (CREB)–binding protein (CBP), J Biol Chem, 287, 7026, 10.1074/jbc.M111.276311 · DOI · Paper page
- Li, 2011, Epithelium-specific deletion of TGF-beta receptor Type II protects mice from bleomycin-induced pulmonary fibrosis, J Clin Invest, 121, 277, 10.1172/JCI42090 · DOI · Paper page
- Kim, 2006, Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix, Proc Natl Acad Sci USA, 103, 13180, 10.1073/pnas.0605669103 · DOI · Paper page
- Prele, 2012, STAT3: a central mediator of pulmonary fibrosis?, Proc Am Thorac Soc, 9, 177, 10.1513/pats.201201-007AW · DOI
- Lai, 2004, Signal transducer and activator of transcription–3 activation contributes to high tissue inhibitor of metalloproteinase–1 expression in anaplastic lymphoma kinase–positive anaplastic large cell lymphoma, Am J Pathol, 164, 2251, 10.1016/S0002-9440(10)63781-9 · DOI
- Garcia-Alvarez, 2006, Tissue inhibitor of metalloproteinase–3 is up-regulated by transforming growth factor–beta1 in vitro and expressed in fibroblastic foci in vivo in idiopathic pulmonary fibrosis, Exp Lung Res, 32, 201, 10.1080/01902140600817481 · DOI
- Artlett, 2011, The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis, Arthritis Rheum, 63, 3563, 10.1002/art.30568 · DOI · Paper page
- Kalliolias, 2008, The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis, Expert Opin Investig Drugs, 17, 349, 10.1517/13543784.17.3.349 · DOI
- Emsley, 2005, A randomised Phase II study of interleukin-1 receptor antagonist in acute stroke patients, J Neurol Neurosurg Psychiatry, 76, 1366, 10.1136/jnnp.2004.054882 · DOI · Paper page
Cited by
Hogan, B. L. M., Barkauskas, C. E., Chapman, H. A., Epstein, J. A., Jain, R., Hsia, C. C. W., Niklason, L., Calle, E., Le, A., Randell, S. H., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.07.012 · Cited by 876
Pathogenic Mechanisms Underlying Idiopathic Pulmonary Fibrosis
Moss, B. J., Ryter, S. W., & Rosas, I. O. (2022) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-042320-030240 · Cited by 821
Developmental pathways in the pathogenesis of lung fibrosis
Chanda, D., Otoupalova, E., Smith, S. R., Volckaert, T., De Langhe, S. P., & Thannickal, V. J. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.08.004 · Cited by 514
Hinz, B. (2016) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.009 · Cited by 424
Lehmann, M., Korfei, M., Mutze, K., Klee, S., Skronska-Wasek, W., Alsafadi, H. N., Ota, C., Costa, R., Schiller, H. B., Lindner, M., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02367-2016 · Cited by 403
Self-citation
Metadata
- Authors
- Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-01
- Volume
- 49
- Issue
- 1
- Pages
- 96-104
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2125890978
- Cited by
- 181
- References
- 12
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis. https://app.cochat.ai/papers/10.1165/rcmb.2012-0524oc
- The paper
- Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013). WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. https://doi.org/10.1165/rcmb.2012-0524oc
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.